Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
Introduction
GlobalData’s “Negative Pressure Wound Therapy (NPWT)Pipeline Technology and Market Forecasts to 2016” report is an essential source of information and analysis on t
Markt: Gesundheitswesen
|
2009 |
2.000,00$ |
Global Advanced Wound Management: Market Analysis and Opportunity Assessment
Introduction
GlobalData’s “Global Advanced Wound Management: Market Analysis and Opportunity Assessment” provides key data, information and analysis on the global advanced wound m
Markt: Gesundheitswesen
|
2009 |
3.500,00$ |
Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets
A detailed clinical and commercial assessment of all key cardiovascular and metabolic therapy areas. / / An analysis of the portfolios of top 10 leading cardiovascular and metabolic companies. / / Sales based sales forecasts for all key cardiovascular and metabolic active agents in the seven major
Markt: Gesundheitswesen
|
2009 |
15.200,00$ |
Global Ophthalmic Market: Focus on Glaucoma
The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed like glaucoma as a disease, types of glaucoma, and treatment of glaucoma. Global as well as US market size and forecasts are given for ophthalmic as well as glaucoma market. The market trends a
Markt: Gesundheitswesen , Diagnostik / Medizintechnik
|
2009 |
800,00$ |
Global Medical Tourism
The wealthy citizens of developing countries have frequently traveled to the U.S. and Western Europe to seek the expertise and gain access to advanced technology available at leadi
Markt: Gesundheitswesen
|
2008 |
1.999,00$ |
Mammography World Markets
The women's mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher i
Markt: Gesundheitswesen
|
2008 |
3.400,00$ |
Report for the investigation of chinese medical and pharmaceutical CRO market (2008)
Markt: Gesundheitswesen
|
2008 |
1.500,00$ |
The Promotional Landscape in US and Europe: Benchmarking promotional ROI and optimizing detailing and journal spend
The Promotional Landscape in the US and Europe
Benchmarking promotional ROI and optimizing detailing and journal spend relationships
Promotional activities within the pharma indus
Markt: Gesundheitswesen
|
2008 |
3.835,00$ |
The Top Ten Specialty Pharmaceutical Companies: Positioning, performance and SWOT analyses
The Top Ten Specialty Pharmaceutical Companies
Positioning, performance and SWOT analyses
Specialty pharmaceutical companies focus the majority of their efforts upon one or two th
Markt: Gesundheitswesen
|
2008 |
3.835,00$ |
Biotech M&A Strategies: Deal assessments, trends and future prospects
M&A activity in the pharma industry continues to gain momentum as a growing number of companies seek to replenish drug pipelines through biotechnology acquisitions. M&As be
Markt: Gesundheitswesen
|
2008 |
3.835,00$ |
The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
The dermatology market remains highly competitive, with developers ranging from Big Pharma to biotechnology and specialty pharmaceutical firms. In recent years levels of innovation
Markt: Gesundheitswesen
|
2008 |
3.835,00$ |
Amgen Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Amgen in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeli
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
AstraZeneca plc: PharmaVitae Profile
This analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
Bayer Schering Pharma AG: PharmaVitae Profile
This analysis examines the historical and forecast performance for Bayer Schering Pharma in the ethical pharma sector. The profile encompasses global company strategy, portfolio an
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
Bristol-Myers Squibb Co.: PharmaVitae Profile
This analysis examines the historical and forecast performance for BMS in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population
Analysis of clinical trial design and treatment guidelines in fibromyalgia. / / Fibromyalgia market sizing assessment with detailed methodology. / / Detailed profiles of key late-stage pipeline products for fibromyalgia, with indication-specific forecasts to 2017. / / Case study analysis of Pfize
Markt: Gesundheitswesen
|
2008 |
15.200,00$ |
Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead
Assessment of pneumococcal and zoster disease incidence, in-depth analysis of existing vaccines and key pipeline compounds / / Review of current and expected future immunization guidelines as well as existing and forecast immunization rates / / 10-year sales forecast on a population basis for Zos
Markt: Gesundheitswesen
|
2008 |
15.200,00$ |
Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth
Analysis of the performance of each of the cytotoxic therapy cancer brands in the seven major markets, forecast to 2017
/
/ Analysis and segmentation of the market at various levels including drug class, indication, company and sales growth rate
/
/ Assessment of the leading cancer brands and
Markt: Gesundheitswesen
|
2008 |
15.200,00$ |
Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbusters by 2017
Forecast sales of every marketed targeted therapy cancer brand in each of the seven major markets over the period 2007 to 2017
/
/ Analysis and segmentation of the market at various levels including drug class, indication, company and mode of administration
/
/ Comprehensive brand profiles and
Markt: Gesundheitswesen
|
2008 |
15.200,00$ |
Financial Deals Industry Tracker: Pharmaceuticals and Healthcare (analysis of monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, venture financing, private placement, initial public offeri
Insights into deal activity across M&A, private equity, private placement, IPO, and secondary offering deals / In-depth analysis on all key sectors, namely biotechnology, healthcare services, medical devices, and pharmaceuticals / Geographical trends by primary regions and by key emerging markets
Markt: Gesundheitswesen
|
2008 |
495,00$ |
Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition
Review of key reasons why lifecycle management is important now / / Analysis of key considerations Pharma need to take care of when devising lifecycle management strategies / / Discussion of most commonly used lifecycle management strategies / / Case study analysis of successful and unsuccessful
Markt: Gesundheitswesen
|
2008 |
7.600,00$ |
Johnson & Johnson: PharmaVitae Profile
This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
Novo Nordisk A/S: PharmaVitae Profile
This analysis examines the historical and forecast performance for Novo Nordisk in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
Pipeline Insight: Insulin antidiabetics - Return to injections alternative delivery methods fall by the wayside
Comprehensive analysis of the current insulin antidiabetic pipeline detailing the broad range of developmental classes. / / A detailed clinical and commercial assessment of all key emerging therapies. / / Sales based sales forecasts for key late-stage developmental non-insulin antidiabetics agents
Markt: Gesundheitswesen
|
2008 |
11.400,00$ |
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
Overview of the Rx-to-OTC strategy, analyzing why, when, where, what and how to implement such a switch strategy / / Identification of drivers and resistors of Rx-to-OTC switching across the seven major pharmaceutical markets / / Case study analysis of the most recent Rx-to-OTC switches
Markt: Gesundheitswesen
|
2008 |
5.700,00$ |
